Dapsone and Meclizine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Dapsone (dapsone) and Meclizine (meclizine hydrochloride). Common drug interactions include dermatitis contact among females and anxiety among males.

The phase IV clinical study analyzes what interactions people have when they take Dapsone and Meclizine. It is created by eHealthMe based on reports of 44 people who take the same drugs from the FDA, and is updated regularly.

What is Dapsone?

Dapsone has active ingredients of dapsone. It is often used in dermatitis herpetiformis. eHealthMe is studying from 11,732 Dapsone users. Check the latest studies of Dapsone.

What is Meclizine?

Meclizine has active ingredients of meclizine hydrochloride. It is often used in dizziness. eHealthMe is studying from 23,116 Meclizine users. Check the latest studies of Meclizine.



On Jul, 11, 2026

44 people who take Dapsone and Meclizine together, and have interactions are studied.

Dapsone and Meclizine drug interactions.

What are the common drug interactions of Dapsone and Meclizine, by gender? *:

female:

  1. Dermatitis contact (skin reaction (dermatitis) resulting from exposure to allergens)
  2. Dry eye (lack of adequate tears)
  3. Dry mouth
  4. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
  5. Fall
  6. Gastritis (inflammation of stomach)
  7. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  8. General physical health deterioration (weak health status)
  9. Glare (difficulty seeing in the presence of bright light)
  10. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)

male:

  1. Anxiety
  2. Pain
  3. Vomiting
  4. Serum sickness (hypersensitivity reaction that results from the injection of heterologous or foreign protein or serum)
  5. Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin)
  6. Abdominal pain
  7. Abdominal pain lower
  8. Abscess (pus)
  9. Adverse event
  10. Ankle fracture

What are the common drug interactions of Dapsone and Meclizine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Anxiety
  2. Pain
  3. Vomiting
  4. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  5. Dehydration (dryness resulting from the removal of water)
  6. Diarrhoea
  7. Emotional distress
  8. Fanconi syndrome acquired (self developed genetic disease of kidney damage due to defective transport system)
  9. Pancreatitis (inflammation of pancreas)
  10. Arachnoiditis (neuropathic disease caused by inflammation of the arachnoid)

50-59:

  1. Erythema (redness of the skin)
  2. Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)
  3. Gait disturbance
  4. Hiv infection
  5. Hypertonia (abnormal increase in muscle tension and a reduced ability of a muscle to stretch)
  6. Hypoaesthesia (reduced sense of touch or sensation)
  7. Joint range of motion decreased (disease of joint movement)
  8. Knee arthroplasty
  9. Mobility decreased (ability to move is reduced)
  10. Muscle tightness

60+:

  1. Anxiety
  2. Pain
  3. Dry mouth
  4. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
  5. Fall
  6. Gastritis (inflammation of stomach)
  7. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  8. General physical health deterioration (weak health status)
  9. Glare (difficulty seeing in the presence of bright light)
  10. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)

What are the existing conditions these people have? *

  1. Osteoporosis (bones weak and more likely to break): 16 people, 36.36%
  2. Hiv Infection: 10 people, 22.73%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 11.36%
  4. Stress And Anxiety: 4 people, 9.09%
  5. Pain: 4 people, 9.09%
  6. Multiple Myeloma (cancer of the plasma cells): 3 people, 6.82%
  7. Depression: 3 people, 6.82%

* Approximation only. Some reports may have incomplete information.

Do you take Dapsone and Meclizine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Dapsone and Meclizine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Dapsone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Meclizine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Dapsone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Meclizine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on dapsone and meclizine hydrochloride (the active ingredients of Dapsone and Meclizine, respectively), and Dapsone and Meclizine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: